ALIX has recently been discovered to upregulate MT1-MMP and MMP-9 expression and the depletion of ALIX attenuates the invasive/migrative activity of head and neck cell carcinoma (HNSCC) cells [78]. Here, PDCD6IP is linked to head and neck squamous cell carcinoma.